INNATE PHARMA (EPA:IPH) INNATE PHARMA RELEASES ITS FINANCIAL CALENDAR FOR 2020

Retour

Directive transparence : information réglementée

04/12/2019 07:00

04/12/2019 07:00

INNATE PHARMA RELEASES ITS FINANCIAL CALENDAR FOR 2020

03/12/2019 07:00

Innate Pharma Certified as a Great Place to Work®

13/11/2019 07:00

Innate Pharma third quarter 2019 report

13/09/2019 14:30

Innate Pharma : HALF-YEAR FINANCIAL REPORT 2019

13/09/2019 07:00

Innate Pharma reports first half 2019 financial results and business update

20/06/2019 07:00

Innate Pharma to host key opinion leader call on IPH4102 “TELLOMAK”...

12/06/2019 10:00

Innate Pharma to present IPH4102 “TELLOMAK” clinical trial design and...

11/12/2012 07:15

Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) updates on four...

23/11/2012 07:30

Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) announces that its...

14/11/2012 07:15

Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) announces revenue...

Voir tous les communiqués de INNATE PHARMA